RUNX3 Antibodies

Santa Cruz Biotechnology delivers a wide array of RUNX3 monoclonal antibodies for investigating RUNX3 in various biological processes. RUNX3 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RUNX3 is a critical transcription factor involved in the regulation of gene expression, playing a significant role in processes such as cell differentiation, development, and immune response. RUNX3's importance is demonstrated by its involvement in tumor suppression and its association with various cancers, making it a key target for therapeutic research. Understanding RUNX3 function can provide insights into disease mechanisms and potential treatment strategies. RUNX3 monoclonal antibodies enable precise detection and analysis of RUNX3 expression patterns across different cell types and tissues. Researchers can utilize RUNX3 monoclonal antibodies to examine protein-protein interactions and cellular localization patterns. Advanced research techniques incorporating RUNX3 monoclonal antibodies help reveal molecular pathways and regulatory mechanisms. Santa Cruz Biotechnology RUNX3 monoclonal antibodies support the scientific community in advancing cancer research and therapeutic development.